The Cost Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas aeruginosa in Patients with Cystic Fibrosis
Under their list prices, neither DPI product is likely to represent good value for money for the NHS given current cost-effectiveness thresholds. The PAS discounts have a significant impact upon the economic attractiveness of both DPI products compared against nebulised tobramycin. The clinical effectiveness and cost effectiveness of the DPIs against other nebulised antibiotics, such as aztreonam and inhaled colistimethate sodium, remains unclear. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Year of publication: |
2014
|
---|---|
Authors: | Tappenden, Paul ; Harnan, Sue ; Uttley, Lesley ; Mildred, Matthew ; Walshaw, Martin ; Taylor, Christopher ; Brownlee, Keith |
Published in: |
PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 32.2014, 2, p. 159-172
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Uttley, Lesley, (2013)
-
Have Communication Technologies Influenced Rural Social Work Practice?
Brownlee, Keith, (2015)
-
Returns to education and occupations for Canadian Aboriginal people
Fan, Lida, (2017)
- More ...